SCHEMBL1093530

SCHEMBL1093530

COC(=O)c1c[nH]c2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 10/20 1.00
CREBBP Q92793 1/20 1.00
PBRM1 Q86U86 1/20 0.66
GPR84 Q9NQS5 1/20 0.65
RAB9A P51151 1/20 0.62
ALDH1A1 P00352 1/20 0.61
ATM Q13315 1/20 0.61
MEN1 O00255 1/20 0.60
MAPT P10636 1/20 0.60
KMT2A Q03164 1/20 0.60
MAP2K1 Q02750 1/20 0.59
TP53 P04637 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
ALOX5 P09917 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30031033 1.00 NR4A2 (1.00) NR4A2CREBBPPBRM1GPR84RAB9A
Hydrochloric Acid SCHEMBL28254334 0.98 NR4A2 (0.97) NR4A2CREBBPPBRM1GPR84RAB9A
SCHEMBL28327513 0.89 NR4A2 (0.80) NR4A2CREBBPPBRM1GPR84RAB9A
SCHEMBL21438794 0.89 NR4A2 (0.79) NR4A2CREBBPPBRM1GPR84RAB9A
SCHEMBL29696613 0.88 NR4A2 (0.79) NR4A2CREBBPPBRM1GPR84RAB9A
SCHEMBL2052030 0.88 NR4A2 (0.79) NR4A2CREBBPPBRM1GPR84RAB9A
SCHEMBL21439506 0.84 TP53 (0.74) NR4A2CREBBPPBRM1GPR84RAB9A
SCHEMBL28579575 0.84 NPC1 (0.72) NR4A2CREBBPPBRM1GPR84RAB9A
SCHEMBL30658176 0.83 NR4A2 (0.71) NR4A2CREBBPPBRM1GPR84RAB9A
SCHEMBL729076 0.83 NR4A2 (0.71) NR4A2CREBBPPBRM1GPR84RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 777 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119819370-A Preparation method of photocatalytic degradation material for treating acid chrome blue K sewage 北方工业大学 2025-04-15 CN claimed
CN-116332941-B Synthesis method of lactam-indoline structure compound 中国石油大学(华东) 2024-04-12 CN claimed
CN-114181928-B Immobilized microbial agent for repairing marine petroleum pollution 浙江省海洋水产研究所 2023-10-31 CN claimed
US-11751573-B2 Seaweed composition PORT LOUIS BERNARD (SC) 2023-09-12 US claimed
CN-116332941-A Synthesis method of lactam-indoline structure compound 中国石油大学(华东) 2023-06-27 CN claimed
CN-109678810-B 1,2-oxygen nitrogen heterocyclic butane compound and preparation method and application thereof 南京工业大学 2022-10-28 CN claimed
CN-114149356-A Preparation method of methyl indolcarbate compound 安徽益多康尔医药科技有限公司 2022-03-08 CN claimed
CN-113683567-A Synthesis method of novel estrogen receptor targeting inhibitor and application of novel estrogen receptor targeting inhibitor in breast cancer treatment 杨锦飞 2021-11-23 CN claimed
CN-111269397-B Polymerization method and polymer prepared by same 中国科学院福建物质结构研究所 2021-05-11 CN claimed
CN-108409731-B Chiral resolution of aryl-substituted 1H-pyridine [3,4-b ] indole-3-carboxylic acid methyl ester 西华大学 2020-11-20 CN claimed
CN-1671706-A Modified pictet-spengler reaction and products prepared therefrom LILLY ICOS LLC (US) 2005-09-21 CN claimed
CN-1633296-A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof BOEHRINGER INGELHEIM PHARMA (US) 2005-06-29 CN claimed
CN-1625411-A Combination of a NSAID and a PDE-4 inhibitor ALTANA PHARMA AG (DE) 2005-06-08 CN claimed
US-20040063758-A1 INHIBITORS OF BACTERIAL NAD SYNTHETASE BROUILLETTE WAYNE J (US) 2004-04-01 US claimed
JP-2002509149-A 2002-03-26 JP claimed
EP-1109805-A1 INHIBITORS OF BACTERIAL NAD SYNTHETASE The UAB Research Foundation (US) 2001-06-27 EP claimed
EP-1047692-A1 METHODS OF SYNTHESIZING AND SCREENING INHIBITORS OF BACTERIAL NAD SYNTHETASE ENZYME, COMPOUNDS THEREOF AND METHODS OF TREATING BACTERIAL AND MICROBIAL INFECTIONS WITH THESE INHIBITORS THE UAB RESEARCH FOUNDATION (US) 2000-11-02 EP claimed
WO-2000010996-A1 INHIBITORS OF BACTERIAL NAD SYNTHETASE THE UAB RESEARCH FOUNDATION (US) 2000-03-02 WO claimed
WO-1999036422-A1 METHODS OF SYNTHESIZING AND SCREENING INHIBITORS OF BACTERIAL NAD SYNTHETASE ENZYME, COMPOUNDS THEREOF, AND METHODS OF TREATING BACTERIAL AND MICROBIAL INFECTIONS WITH INHIBITORS OF BACTERIAL NAD SYNTHETASE ENZYME THE UAB RESEARCH FOUNDATION (US) 1999-07-22 WO claimed
EP-0360638-A1 Process for dyeing keratinous fibres with an indole derivative associated with a nitrite, and composition therefor L'OREAL (FR) 1990-03-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063758-A1 INHIBITORS OF BACTERIAL NAD SYNTHETASE COASY, NADK, NQO1 NR4A2 2745/4885CREBBP 737/4885PBRM1 2717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.